论文部分内容阅读
目的:对氨茶碱和地塞米松雾化吸入治疗儿童喘息性支气管肺炎的临床疗效进行探讨观察。方法:随机抽取本院2012年2月~2013年2月本院接诊的100例小儿喘息型支气管肺炎患者作为研究对象,将其随机分为观察组和对照组。对照组患者保持呼吸道通畅,行抗感染止咳去痰的方式,静脉滴注氨茶碱,氢化可的松琥珀酸钠治疗;观察组患者保持呼吸道通畅,抗感染止咳去痰,辅以雾化吸入氨茶碱,地塞米松治疗。观察两组患者临床症状消失时间、药物不良反应率和有效率。结果:观察组总有效率98.0%,对照组总有效率94.0%,二者无显著性差异(P>0.05);两组患者在住院时间方面,无显著性差异(P>0.05),在咳嗽消失时间、肺部罗音消失时间、喘息消失时间的对比上,二者差异显著(P<0.05);观察组患者在呕吐、抽搐、哭闹、心跳加快、食欲下降等方面均显著优于对照组,二者比较差异显著(P<0.05)。结论:氨茶碱和地塞米松雾化吸入治疗儿童喘息性支气管肺炎疗效显著,药物不良反应少,值得临床使用。
Objective: To study the clinical efficacy of aminophylline and dexamethasone inhalation in the treatment of asthmatic bronchopneumonia in children. Methods: A total of 100 pediatric asthmatic bronchial pneumonia patients admitted from February 2012 to February 2013 in our hospital were randomly selected as the study subjects, which were randomly divided into observation group and control group. The patients in the control group were kept in the airway, anti-cough and phlegm-resistant manner, intravenous infusion of aminophylline, hydrocortisone sodium succinate treatment; observation group patients to maintain airway patency, anti-cough and sputum anti-infective, supplemented by inhalation of ammonia tea Alkali, dexamethasone treatment. Two groups of patients were observed the disappearance of clinical symptoms, adverse drug reaction rates and efficiency. Results: The total effective rate was 98.0% in the observation group and 94.0% in the control group, there was no significant difference between the two groups (P> 0.05). There was no significant difference in the length of hospital stay between the two groups (P> 0.05) (P <0.05). The observation group was significantly better than the control group in the aspects of vomiting, convulsions, crying, rapid heartbeat, loss of appetite, etc. Group, the difference was significant (P <0.05). Conclusion: Aminophylline and dexamethasone nebulized inhalation treatment of asthmatic bronchopneumonia in children with significant effect, less adverse drug reactions, it is worth clinical use.